Spasticity, following the neurological disorder of cerebral palsy (CP), describes a
pathological condition, the central feature of which is involuntary and prolonged muscle …

Spasticity, following the neurological disorder of cerebral palsy (CP), describes a
pathological condition, the central feature of which is involuntary and prolonged muscle …

Physics-based simulations of walking have the theoretical potential to support clinical
decision-making by predicting the functional outcome of treatments in terms of walking …

Aim Clinical determination of spasticity is confounded by the difficulty in distinguishing reflex
from passive contributions to muscle stiffness. There is, therefore, a risk that children with …

BACKGROUND: Although botulinum toxin is a well-established treatment of focal spasticity
in cerebral palsy, most trials have been small, and few have simultaneously assessed …

BACKGROUND: In the United States, many children with cerebral palsy (CP) obtain health
care coverage through managed Medicaid, but little is known about the current …

Purpose: Investigate the combination effects of strength training and Botulinum Toxin Type-A
(BoNT-A) on muscle strength and morphology in children with Cerebral Palsy (CP) …

Introduction To detect ideal locations for botulinum toxin (BoNT) injection by exploring the
intramuscular nerve arborization of the psoas major and iliacus muscles. Method A modified …

Aim This study aimed to track alterations in muscle volume for 6 months in children with
cerebral palsy (CP) after the first exposure to botulinum neurotoxin A (Bo NT‐A), a …

Objectives In the last 2 decades, BTX-A is increasingly being used in the management of
spasticity in children with Cerebral Palsy (CP) and there is no doubt about its effect on range …